[ad_1]
Our Work
CDC’s National Center on Birth Defects and Developmental Disabilities (NCBDDD) works to address substance use during pregnancy. NCBDDD also works to improve care for affected individuals and their families. CDC does this work through the following activities:
- Collecting and analyzing data on substance exposure during pregnancy, the impact of evidence-based programs, and the occurrence of negative infant outcomes
- Implementing programs to inform policies for practice and systems change
- Working with partners to develop and implement evidence-based interventions and clinical guidelines for the care of mothers and babies
- Conducting communication activities to increase awareness and sharing new findings in a timely manner
Related Articles
Polysubstance Use During Pregnancy: The Importance of Screening, Patient Education, and Integrating a Harm Reduction Perspective
Drug and Alcohol Dependence 2023;247:109872. DOI: 10.1016/j.drugalcdep.2023.109872
Board A, D’Angelo DV, Salvesen von Essen B, Denny CH, Miele K, Dunkley J, Baillieu R, Kim SY.
[Read Article]
Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009–2020
Maternal Child and Health Journal 2023; DOI: 10.1007/s10995-023-03592-w
Tran EL, England LJ, Park Y, Denny CH, Kim SY.
[Read Article]
Alcohol Use and Co-use of Other Substances Among Pregnant Females Aged 12–44 Years – United States, 2015–2018
Morbidity and Mortality Weekly Report; August 7, 2020; 69(31): 1009-1014
England LJ, Bennett C, Denny CH, Honein MA, Gilboa SM, Kim SY, Guy GP, Tran EL, Rose CE, Bohm MK, Boyle CA.
[Read Article]
More Information
1England LJ, Bennett C, Denny CH, et al. Alcohol use and co-use of other substances among pregnant females aged 12–44 years – United States, 2015–2018. MMWR Morb Mortal Wkly Rep 2020; 69(31): 1009-1014.
2Ko JY, Coy KC, Haight SC, et al. Characteristics of marijuana use during pregnancy – eight states, Pregnancy Risk Assessment Monitoring System, 2017. MMWR Morb Mortal Wkly Rep 2020; 69(32): 1058-1063.
3Jarlenski M, Barry CL, Gollust S, et al. Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons. Am J Public Health 2017; 107(8):1308–1310.
4Patrick SW, Dudley J, Martin PR, et al. Prescription opioid epidemic and infant outcomes. Pediatrics 2015;135(5):842–850.
[ad_2]